dipyridamole has been researched along with Compensatory Hyperinsulinemia in 4 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Caffeine decreased insulin sensitivity by 15% (P < 0." | 9.10 | Caffeine can decrease insulin sensitivity in humans. ( De Galan, BE; Keijzers, GB; Smits, P; Tack, CJ, 2002) |
| "Caffeine decreased insulin sensitivity by 15% (P < 0." | 5.10 | Caffeine can decrease insulin sensitivity in humans. ( De Galan, BE; Keijzers, GB; Smits, P; Tack, CJ, 2002) |
| "Rest/dipyridamole H(15)2O and 18FDG PET studies were performed in 23 patients with left ventricular dysfunction." | 3.72 | Myocardial perfusion and glucose uptake coupling in CAD patients. ( André-Fouët, X; Comar, D; Croisille, P; Duisit, J; Fol, S; Janier, MF; Mazzadi, AN; Ovize, M, 2003) |
| "Pravastatin treatment, resulting in decreased LDL oxidation, did not improve myocardial perfusion reserve in subjects with type 1 diabetes." | 2.71 | Effect of pravastatin on low-density lipoprotein oxidation and myocardial perfusion in young adults with type 1 diabetes. ( Ahotupa, M; Janatuinen, T; Knuuti, J; Nuutila, P; Raitakari, OT; Rönnemaa, T; Toikka, JO, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kofoed, KF | 1 |
| Hove, JD | 1 |
| Freiberg, J | 1 |
| Høst, U | 1 |
| Holm, S | 1 |
| Kelbaek, H | 1 |
| Mazzadi, AN | 1 |
| Croisille, P | 1 |
| André-Fouët, X | 1 |
| Fol, S | 1 |
| Duisit, J | 1 |
| Ovize, M | 1 |
| Comar, D | 1 |
| Janier, MF | 1 |
| Janatuinen, T | 1 |
| Knuuti, J | 1 |
| Toikka, JO | 1 |
| Ahotupa, M | 1 |
| Nuutila, P | 1 |
| Rönnemaa, T | 1 |
| Raitakari, OT | 1 |
| Keijzers, GB | 1 |
| De Galan, BE | 1 |
| Tack, CJ | 1 |
| Smits, P | 1 |
3 trials available for dipyridamole and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Variability of insulin-stimulated myocardial glucose uptake in healthy elderly subjects.
Topics: Ammonia; Blood Glucose; Dipyridamole; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Hear | 2002 |
Effect of pravastatin on low-density lipoprotein oxidation and myocardial perfusion in young adults with type 1 diabetes.
Topics: Adult; Coronary Circulation; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dipyridamole; Double- | 2004 |
Caffeine can decrease insulin sensitivity in humans.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Dipyridamole; Double-Blind Method; Epinephrine; | 2002 |
1 other study available for dipyridamole and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Myocardial perfusion and glucose uptake coupling in CAD patients.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Dipyridamole; Fatty Acids, Nonester | 2003 |